RecruitingNCT04322734
Transgenerational Metabolic-Immune Biomarkers of Neurological and Neurodevelopmental Disorders
Sponsor
Southwest Autism Research & Resource Center
Enrollment
500 participants
Start Date
Dec 13, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
The study involves up to 5 visits for a fasting blood draw, behavioral assessments, and/or questionnaires. Other samples may be collected when appropriate. This study is currently recruiting. There is no cost for visits or study-related exams.
Eligibility
Max Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This study is looking at biological markers in blood and other samples from children with autism spectrum disorder (ASD), epilepsy, brain tumors, other neurological conditions, and typically developing children. The goal is to understand if there are biological signals in a child's body — and even from their parents — that could help researchers better understand why these conditions happen.
**You may be eligible if...**
- Your child is between 0 and 17 years old (up to age 17 years, 11 months)
- Your child has a diagnosis of autism spectrum disorder, epilepsy, a brain tumor, or another neurological or neurodevelopmental condition
- Your child is typically developing (for the comparison group)
**You may NOT be eligible if...**
- Your child has had a serious bad reaction to a blood draw in the past
- Your child (if female and of reproductive age) is pregnant or planning to become pregnant
- There is another medical or personal reason the investigator believes makes participation unsafe
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04322734
Related Trials
Investigation of Blood-Brain-Barrier Breakdown Using Manganese Magnetic Resonance Imaging in Drug-Resistant Epilepsy
NCT025318801 location
A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations
NCT055881411 location
Tumor Related Epilepsy
NCT026393251 location
Promoting Emotional and Autonomic Control Through Guided Breathing Exercises for Emerging Adults With Autism
NCT072381532 locations
AI-Based Mobile Intervention on Medication Non-Adherence and Transition
NCT074450742 locations